KIT signaling through PI3K and PLC gamma is attenuated after SH3BP2 silencing in GIST, so it is conceivable that selective miRNA expression dependent on KIT signaling will be altered as well. The gene discussed is SH3BP2; the disease is gastrointestinal stromal tumor.